Eton Pharmaceuticals, Inc. (ETON) News
Filter ETON News Items
ETON News Results
|Loading, please wait...|
ETON News Highlights
- For ETON, its 30 day story count is now at 5.
- Over the past 4 days, the trend for ETON's stories per day has been choppy and unclear. It has oscillated between 2 and 3.
- The most mentioned tickers in articles about ETON are RANI, RARE and ACET.
Latest ETON News From Around the Web
Below are the latest news stories about Eton Pharmaceuticals Inc that investors may wish to consider to help them evaluate ETON as an investment opportunity.
DEER PARK, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the second quarter ended June 30, 2021.
Eton Pharmaceuticals, Inc. (ETON) delivered earnings and revenue surprises of 42.86% and -19.92%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
The company, Eton Pharmaceuticals Inc Registered Shs, is set to host investors and clients on a conference call on 8/16/2021 3:17:10 PM. The call comes after the company''s earnings, which are set to be announced on 8/16/2021.Investors, or members of the public who wish to dial in, can join the call by visiting
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (NASDAQ: ADGI ) (IPOed Friday) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Cytek Biosciences, Inc. (NASDAQ: CTKB ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Eliem Therapeutics, Inc. (NASDAQ: ELYM ) (IPOed Monday) Erasca, Inc. (NASDAQ: ERAS ) (IPOed July 16) Fulcrum Therapeutics, Inc. (NASDAQ: FULC ) (reacted to positive analyst actions following a positive clinical readout) IN8bio, Inc. (NASDAQ: INAB ) Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD ) Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI ) (announced second-quarter results) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE ) Rani Therapeutics Holdings, ...
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck''s Keytruda On Track For More Label Expansions, Eliem Debuts
Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (NASDAQ: ADGI ) (IPOed Friday) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Axonics, Inc. (NASDAQ: AXNX ) BioLife Solutions, Inc. (NASDAQ: BLFS ) (announced a deal to buy privately-held Sexton Biotech to expand cell and gene therapy tools portfolio) BioNTech SE (NASDAQ: BNTX ) (reacted to its quarterly results and raised vaccine sales forecast) Caribou Biosciences, Inc. (NASDAQ: CRBU ) (IPOed July 23) Cortexyme, Inc. (NASDAQ: CRTX ) (announced its second-quarter results) Cytokinetics, Incorporated (NASDAQ: CYTK ) Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Edward...
According to an SEC filing , the FDA action date for Eton Pharmaceuticals Inc''s (NASDAQ: ETON ) antiepileptic topiramate oral solution has been delayed three months to November 6. An FDA decision was expected on Friday. However, Eton said that Full story available on Benzinga.com
Eton Pharmaceuticals, Inc. (ETON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DEER PARK, Ill., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report second quarter 2021 financial and operating results on Monday, August 16, 2021. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 4:30 p.m. ET (3:30 p.m. CT).
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results. Earnings momentum sent shares of Bristol-Myers Squibb Company (NYSE: BMY ) to a record high midweek, although they have pulled back since then. Pfizer, Inc.''s (NYSE: PFE ) COVID-19 vaccine sales buoyed its quarter results and prompted the company to raise its guidance. Merck & Co, Ltd. (NYSE: MRK ), however, reported a bottom-line miss. The Alzheimer''s Association International Conference presentations moved stocks during the week. Annovis Bio, Inc. (NASDAQ: ANVS ) shares lost about 71% during the week after data presented at the conference failed to cut ice with investors. The week also witnessed a slew of IPOs fr...
A look at the shareholders of Eton Pharmaceuticals, Inc. ( NASDAQ:ETON ) can tell us which group is most powerful...